COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals to Present at Upcoming September Investor Conferences
30/08/2018
NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present a company [...]
VBL Therapeutics Announces Publication of Positive New Data on its Lecinoxoid Drug Candidates for the Treatment of Renal Fibrosis
30/08/2018
These data, together with positive preclinical NASH data previously presented, support the potential of VBL’s lecinoxoid pipeline Recently granted US patent provides patent protection for lecinoxoids treatment of [...]
ChromaDex Announces Participation at The 20th Annual Global Investment Conference in New York City September 5, 2018
30/08/2018
IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and [...]
Infant Bacterial Therapeutics has been approved for listing on the main market of Nasdaq Stockholm
30/08/2018
Nasdaq Stockholm’s Listing Committee has approved the admission of Infant Bacterial Therapeutics AB’s (“IBT” or the “Company”) shares of series B for trading on the main market of Nasdaq Stockholm. The approval is [...]
Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease.
30/08/2018
Press release Malmö, August 30, 2018 Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease. Acarix AB (publ) ("Acarix"), [...]
LIDDS Delårsrapport april-juni 2018
30/08/2018
ANDRA KVARTALET (APRIL - JUNI 2018) Nettoomsättningen uppgick till 0,0 (0,4) MSEK Kostnaderna uppgick till 2,2 (1,6) MSEK Resultatet före och efter skatt uppgick till -2,2 (-1,2) MSEK Resultat per aktie uppgick till -0, [...]
Notification from Oasmia Pharmaceutical AB
30/08/2018
Oasmia Pharmaceutical AB hereby issues a notification that the Company’s loan from Nexttobe AB has according to earlier communication been overtaken by a consortium. Due date for the loan is September 30 th 2019. Notes [...]
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - James Phillips
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - James Phillips Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Aki Prihti
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Aki Prihti Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Frans Wuite
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Frans Wuite Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Pekka Mattila
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Pekka Mattila Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Timo Veromaa
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Timo Veromaa Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Patrick Bourdet, fondateur et ancien PDG d’AREVA Med (Orano Med) entre au capital du Radiopharma Logistics Group (RLG)
30/08/2018
Médicine Nucléaire/ Radiopharmacie/Logistique Loos, France, siège d'Isovital, 28 aout 2018 : Patrick Bourdet, fondateur et ancien PDG d’AREVA Med (Orano Med) entre au capital du Radiopharma Logistics Group (RLG). [...]
Shire plc: Rule 2.9 Announcement
30/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 August 2018 [...]
NeuroSearch A/S – H1 report 2018
30/08/2018
Announcement 30 August 2018 Below please find the H1 report 2018. The full report is available in the enclosed PDF file. NeuroSearch posted an operating loss of DKK 2.8 million in H1 2018 (H2 2017: a loss of DKK 2.3 [...]
PCI Biotech: Second quarter and first half-year 2018 results
30/08/2018
Oslo (Norway), 30 August 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim second quarter and first half-year 2018 result. Please find enclosed the report and [...]
MDxHealth (R): MDxHealth Reports Half Year 2018 Results
30/08/2018
NEWS RELEASE REGULATED INFORMATION INTERIM FINANCIAL REPORT Good Operational Progress and Healthy Double-Digit Growth of Clinical Testing Volumes Conference call for analysts and investors today at 15:00 CET / 09:00 EST [...]

Pages